Supplier Performance
Compare distributors and design a resilient multi-supplier allocation.
Shanghai Pharma
- On-Time Delivery
- 96.4%
- Avg Lead Time
- 42d
- Emergency Success
- 92%
- Fulfillment Acc.
- 99.1%
- Stock Accuracy
- 98.7%
- Cost / Fulfill
- ¥42
- Coverage
- National
- Expiry Score
- 94
Supplier B
- On-Time Delivery
- 89.2%
- Avg Lead Time
- 48d
- Emergency Success
- 78%
- Fulfillment Acc.
- 96.4%
- Stock Accuracy
- 95.1%
- Cost / Fulfill
- ¥36
- Coverage
- South + East
- Expiry Score
- 86
Manufacturer Direct
- On-Time Delivery
- 92.8%
- Avg Lead Time
- 60d
- Emergency Success
- 70%
- Fulfillment Acc.
- 99.6%
- Stock Accuracy
- 99.2%
- Cost / Fulfill
- ¥28
- Coverage
- Strategic Reserve
- Expiry Score
- 98
Supplier Performance Comparison
Normalized score across key dimensions
Recommended Supplier Allocation
Multi-supplier strategy to reduce single-platform dependency
Core SKUs across all regions. Compliance-heavy hospital channels and high-velocity Toric SKUs. Target 65% of fulfillment volume.
South China and selected East China coverage. Emergency replenishment for stockout-risk SKUs. Target 20% of volume.
Critical SKUs and new product launch control (EVO+ Toric). Long lead time but highest accuracy. Target 15% of volume.
Supplier Switching Simulation 供应商切换模拟
What happens if N% of South China replenishment shifts from Shanghai Pharma to Supplier B
Shanghai Pharma lead time drift +3d in South China; service level dropped to 88%.
Supplier B lower fulfillment accuracy (96.4%) and emergency success (78%).
30% to Supplier B for non-strategic SKUs in South China · keep A/X SKUs on Shanghai Pharma.
Supplier Action Tracker 履约动作
Status applied across the platform: Draft · Pending Approval · Approved · In Progress · Completed · Rejected
| Supplier | Action | Reason | Owner | Deadline | Status | Expected Impact |
|---|---|---|---|---|---|---|
| Shanghai Pharma | Request recovery plan | Lead time +3d South China | Supplier Mgmt | 2026-06-12 | Pending Approval | Restore SL 88% → 96% |
| Supplier B | Reallocate 30% S. China | Backup capacity | Supply Planning | 2026-06-10 | Approved | Coverage +18 pp |
| Manufacturer Direct | Reserve EVO+ Toric strategic stock | Launch protection | S&OP | 2026-07-01 | In Progress | Launch SL 98% |